Clinical trial
The Effect of Diflunisal on Familial Amyloidosis
NCT00294671 · Boston University, Other · Completed
Key facts
| NCT number | NCT00294671 |
|---|---|
| Title | The Effect of Diflunisal on Familial Amyloidosis |
| Official title | The Effect of Diflunisal on Familial Amyloidosis |
| Lead sponsor | Boston University, Other |
| Collaborators | Food and Drug Administration (FDA) U.S. Fed National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Familial Amyloid Polyneuropathy, Familial Amyloidosis |
| Intervention type | Drug, Other |
| Interventions | diflunisal, placebo |
| Enrollment | 130 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Feb 22, 2006 |
| Last update posted | Mar 17, 2017 |
| Countries | Italy, Japan, Sweden, United Kingdom, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: